Health Technology Assessment (Jun 2006)
A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1
Abstract
No abstracts available.
Health Technology Assessment (Jun 2006)